Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Bacteria or actinomycetales
Reexamination Certificate
2000-08-03
2003-06-03
Lankford, Jr., Leon B. (Department: 1651)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Bacteria or actinomycetales
C424S094600, C424S780000, C435S252900
Reexamination Certificate
active
06572854
ABSTRACT:
The present invention concerns the use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction, and pharmaceutical or dietetic compositions which contain such bacteria. The invention also concerns a strain of
Lactobacillus brevis
which is highly endowed with arginine deiminase.
The balance between the cell population in an organism can be controlled by way of regulating the rate of proliferation or differentiation or death of the constituent cells (Collins, M. K. L. et al. A.
Trends Biochem. Sci.
18:307, 1993). Cell death during embryogenesis, metamorphosis, hormone-dependent tissue atrophy and the normal turnover of the tissues is referred to as “programmed cell death”. For the large part that event takes place by way of “apoptosis”, a process which is characterised by condensation and segmentation of the nucleus, condensation and fragmentation of the cytoplasm and often fragmentation of the chromosomic DNA into nucleosomal units (Schwartz. L. M. et al
Immunol. Today
14:582, 1993). Apoptosis in the development of vertebrates often occurs when the cells do not receive the extracellular survival signals necessary to suppress an intrinsic cell suicide programme; the survival factors can be produced by the surrounding cells of different type (paracrine mechanism) or of the same type (autocrine mechanism). Apoptosis occurs during embryonic development in particular in complex organs where a given cell sub-population is killed. For example many neurons move in the brain during development, just as auto-reactive T lymphocytes are eliminated in the interior of the thymus. In an adult apoptosis occurs in particular in tissues which are subjected to reversible expansion as in the hormone-dependent cells of the breast and the prostate gland after removal of the hormone or following cytokine-dependent expansion of the haemopoietic cells of the bone marrow.
The modifications which occur in the cell in the course of apoptosis have been widely studied and described (Cohen. J. J. et al
Lab. Clin. Med.
124:761, 1994). Apoptosis is clearly different from necrosis which corresponds to the modifications which occur when cell death derives from cell damage. In necrosis in fact the damaged cells swell up and burst, releasing their intracellular content which is toxic in relation to other cells of the tissue, and triggering off an inflammatory response. In contrast phagocytosis of the apoptotic bodies is so fast as not to induce dispersion of the cellular contents in the extracellular space which otherwise would cause perilesional phlogosis typical of necrosis.
Recent experimental evidence indicates that alterations in cell survival contribute to the pathogenesis of many human diseases including cancer, viral infections, auto-immune diseases, neurovegetative disorders and AIDS (Thompson, C. B.
Science
267:1456, 1995). A treatment aimed at specifically altering apoptosis can have the potential to modify the natural progression of some of those diseases. Both chemotherapy agents and radiation induce the death of tumour cells primarily causing damage to the DNA which in turn causes cell suicide. In addition many tumours conserve some of the physiological cell death control systems which are characteristic of the cells from which they originate. For example cancer of the prostate and cancer of the breast are respectively androgen- and oestrogen-dependent. Therefore anti-androgenic therapy in the treatment of cancer of the prostate gland or removal of oestrogens by means of anti-oestrogens such as tamoxifen in the course of breast cancer are fundamental and universally accepted procedures. Both those methods induce apoptosis in the tumour cells which are otherwise respectively dependent for their survival on androgens or oestrogens. In addition the beneficial effects of glucocorticoids observed in subjects with lymphoidal leukaemia can be attributed to the induction of apoptosis: other substances used for chemotherapy of cancer such as cyclophosphamide, metotrexate, etoposide and cisplatin induce apoptosis of tumour cells (Thatte. U. et al Apoptosis,
Drugs
54:511, 1997).
Previous studies have shown that lactic bacteria present in foods and/or in dietetic/pharmaceutical formulations can cause transitory colonisation of the intestine and have beneficial effects. Survival during the intestinal transit or adhesion to the epithelium seem to be is important for modifying the immune response of the host (Schiffrin. E. J. et al
Am. J. Clin. Nutr.
66: 515S, 1997). The potentially beneficial effects of lactic bacteria include protection from enteric infections, stimulating the secretion of IgA, and inhibition of the growth of intestinal carcinoma, strengthening the activity of IgA. T-cells and macrophages (Perdigon. G. et al
J. Dairy Sci.
78:1597, 1995). In vitro, lactic bacteria have revealed a capacity to stimulate the production of alpha TNF, interleukin (IL)-6 and IL-10 on the part of human mononuclear cells, even to an extent greater than that revealed when using lipopolysaccharide (LPS) as a stimulating agent, confirming a potentiating action on non-specific immunity of the host (Miettinen, M. et al
Infect. Immun.
64:5403, 1996). Still in vitro, lactic bacteria have demonstrated a capacity to absorb mutagenic substances present in cooked foods, confirming the observation that the administration of lactobacilli in man reduces the excretion of mutagenic substance after the ingestion of fried meat and thus the risk of cancer of the colon (Lidbeck, A. et al Eur.
J. Cancer Prev.
1:341, 1992). Experiments conducted with fermented milk with
Bifidobacterium infantis, Bifidobacterium bifidum, Bifidobacterium animalis, Lactobacillus acidophilus,
or
Lactobacillus paracasei
on the growth of breast tumour cells MCF7 have demonstrated that the various fermented milks are capable, even if to varying degrees, of inhibiting the growth of tumour cells. The anti-proliferative effect cannot be correlated to the presence of the bacteria in the fermented milk, to the milk or to the fractions thereof; the hypothesis is for the presence of a soluble compound produced ex novo from the lactic bacteria during fermentation of the milk or microbial transformation of some components of the milk into a biologically active form (Biffi. A. et al
Nutr. Cancer
28:93, 1997).
Many micro-organisms use arginine as a source of carbon, nitrogen and energy. Arginine deiminase transforms arginine in the presence of water into citrulline and ammonia. That enzymatic procedure has been encountered in a variety of pathogenic or potentially pathogenic is bacteria such as Pseudomonas sp and Bacillus sp. and in some types of mycoplasms. It has been demonstrated that this system plays a part in oral ecology, in protecting less acid-tolerant organisms during the fall in the pH to 4, or even lower values, in dental plaque, during glycolysis caused by bacteria which are more resistant to acidity (Curran. T. M.
Appl. Environ. Microbio.
61:4494, 1995).
Studies have been conducted on arginine deiminase which can be obtained from mycoplasms, to be used as a cure for cancer (Takaku, H. et al
Jpn. J. Cancer Res.
1:840, 1995). Mycoplasms are micro-organisms which are similar to bacteria which, unlike the latter, lack a cell wall and the genome of which is around ⅙ of that of
E. coli;
however they can be pathogenic for man, animals and for plants and in addition they cannot be easily handled due to the absence of a cell wall. Purification was thus implemented in respect of the enzyme arginine deiminase which can be obtained from mycoplasms, which behaves like an immunogen and which is not free from undesired effects if used in vivo (McGarrity, J. G. et al U.S. Pat. No. 5,372,942). Other micro-organisms endowed with arginine deiminase (such as for example Pseudomonas sp and Bacillus sp) cannot be used by virtue of their potential pathogenicity and pyrogenicity.
We have now surprisingly found that some bacteria are rich in arginine deiminase, in particular some Gram-positive bacteria
Coe Susan D.
Lankford , Jr. Leon B.
Mendes S.r.l.
Nixon & Vanderhye
LandOfFree
Use of bacteria endowed with arginine deiminase to induce... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of bacteria endowed with arginine deiminase to induce..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of bacteria endowed with arginine deiminase to induce... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3135390